Compounds > l 741626

Page last updated: 2024-09-04

l 741626 and 4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one

l 741626 has been researched along with 4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one in 1 studies

Compound Research Comparison

Studies (l 741626)	Trials (l 741626)	Recent Studies (post-2010) (l 741626)	Studies (4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one)	Trials (4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one)	Recent Studies (post-2010) (4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one)
76	0	33	5	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ablordeppey, SY; Altundas, R; Nkansah, NT; Roth, BL; Setola, V; Sikazwe, DM; Zhu, XY	1

Other Studies

1 other study(ies) available for l 741626 and 4-(3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl)-1-(4-fluorophenyl)butan-1-one

Article	Year
Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups. Bioorganic & medicinal chemistry, 2009, Feb-15, Volume: 17, Issue:4 Topics: Antipsychotic Agents; Binding Sites; Butyrophenones; Haloperidol; Humans; Indoles; Kinetics; Ligands; Receptors, Dopamine D2; Structure-Activity Relationship	2009